MRVI

Maravai LifeSciences Holdings Inc.

Price

$7.22

return (12m)

187.65%

p/e

-10.77

p/bv

2.34

DIVIDEND YIELD

0.00%

MRVI price

Maravai LifeSciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MRVI

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

1.91%

3 months

61.16%

1 year

187.65%

2 years

-21.86%

5 years

-88.09%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals MRVI

Valuation

P/E

-10.77

Sector -2.19

Industry 1.21

P/BV

2.34

Sector 2.22

Industry 2.11

P/Revenue (PSR)

3.99

Sector 2.01

Industry 0.78

EV/EBITDA

-253.24

Sector -17.81

Industry -25.30

EV/EBIT

-53.51

Sector -26.72

Industry -18.04

P/EBITDA

-14.89

Sector 0.36

Industry 0.18

P/EBIT

-7.40

Sector -3.34

Industry 1.26

P/Total Assets

1.38

Sector 1.23

Industry 0.86

P/Net Current Assets

-9.01

Sector -27.35

Industry -12.37

P/Working Capital

7.11

Sector -4.54

Industry -49.48

EPS

-0.52

Sector -0.87

Industry -0.55

BVPS

2.40

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

34.89%

Sector 43.36%

Industry 31.53%

EBITDA Margin

-6.98%

Sector -323.65%

Industry -73.39%

EBIT Margin

-33.03%

Sector -194.57%

Industry -11.94%

Operating Margin

-33.78%

Sector -24.37%

Industry -9.87%

Net Profit Margins

-37.07%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.09

Sector 0.12

Industry 0.22

Profitability

ROE

-21.76%

Sector -33.82%

Industry -37.56%

ROA

-12.82%

Sector -29.63%

Industry -17.56%

ROIC

-11.93%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.05

Sector 1.84

Industry 1.14

Net Debt / EBITDA

-21.14

Sector -1.47

Industry -31.86

Net Debt / EBIT

-4.47

Sector -1.32

Industry 2.06

Net Debt / Equity

0.21

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.41

Sector 0.14

Industry 0.51

Equity/Assets

0.59

Sector 0.42

Industry 0.25

Liabilities/Assets

0.41

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

-23.55%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals MRVI

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MRVI Maravai LifeSciences Holdings Inc.	$7.22	180.93%	0.00%	-10.77	2.34	-21.76%	-37.07%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MRVI Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Maravai LifeSciences

Maravai LifeSciences Holdings Inc.

Average Investor10 user rating

4.0 (2 people)

United States

6 years

Founded: 2020

2020

Time since IPO - 6 years

390

Employees

Maravai LifeSciences Holdings Inc. (United States) is listed on the Nasdaq and has a market capitalization of $833.24 million, with shareholders equity totaling $355.59 million.

The company employs approximately 390 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, Maravai LifeSciences Holdings Inc. reported $208.78 million in revenue, generating net income of $-77.39 million.

Key financial metrics include a P/E ratio of -10.77, a price-to-book (P/B) ratio of 2.34, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MRVI.

Market cap

$833.24 million

Net worth

$355.59 million

$355,590,000.00

Assets

$603.75 million

$603,750,000.00

Total Shares Outstanding

148.00 million

148,000,000

Average Daily Trading Volume

$2.84 million

$2,838,781.32

Sector

Health

Industry

Life Science Tools and Services

MRVI

MRVI revenue and profits

Financial Results MRVI

DRAG THE FRAME TO SEE MORE DATA

MRVI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87